Exploring anti-TGF-β therapies in cancer and fibrosis
Author:
Publisher
Informa UK Limited
Subject
Cell Biology,Clinical Biochemistry,Endocrinology
Link
http://www.tandfonline.com/doi/pdf/10.3109/08977194.2011.595411
Reference143 articles.
1. Transforming growth factor beta-1 in rectal tumour, mucosa and plasma in relation to radiotherapy and clinical outcome in rectal cancer patients
2. TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma
3. Making sense of latent TGFβ activation
4. Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosis
Cited by 124 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Vactosertib potently improves anti-tumor properties of 5-FU for colon cancer;DARU Journal of Pharmaceutical Sciences;2023-09-23
2. Drug Repurposing of Clinically Approved Drugs to Target Epithelial-mesenchymal Transition Using Molecular Docking Approach;SEPTEMBER 2023;2023-09-11
3. Structure-Guide Design and Optimization of Potential Druglikeness Inhibitors for TGFβRI with the Pyrrolopyrimidine Scaffold;Pharmaceuticals;2022-10-13
4. The Promises of Natural Killer Cell Therapy in Endometriosis;International Journal of Molecular Sciences;2022-05-16
5. Epithelial-Mesenchymal Transition and its Role in Renal Fibrogenesis;Brazilian Archives of Biology and Technology;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3